Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ACORN CAPITAL ADVISORS, LLC (CIK 2054410) reported $366.5M across 20 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: CGON ($80.4M, 21.94%), URGN ($61.6M, 16.80%), TRVI ($40.0M, 10.92%), CADL ($36.0M, 9.83%), PBYI ($33.5M, 9.14%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | $80.4M | 21.94% | 1.1M | Added |
| 2 | URGN | UROGEN PHARMA LTD | $61.6M | 16.80% | 1.7M | Hold |
| 3 | TRVI | TREVI THERAPEUTICS INC | $40.0M | 10.92% | 2.1M | Hold |
| 4 | CADL | CANDEL THERAPEUTICS INC | $36.0M | 9.83% | 3.5M | Hold |
| 5 | PBYI | PUMA BIOTECHNOLOGY INC | $33.5M | 9.14% | 4.1M | Hold |
| 6 | JBIO | JADE BIOSCEINCES INC | $21.9M | 5.98% | 986,760 | Added |
| 7 | BCAX | BICARA THERAPEUTICS | $19.1M | 5.21% | 643,381 | Trimmed |
| 8 | KPTI | KARYOPHARM THERAPEUTICS INC | $14.8M | 4.05% | 1.5M | Added |
| 9 | OKUR | ONKURE THERAPEUTICS INC | $12.9M | 3.53% | 2.8M | Hold |
| 10 | HELP | HELUS PHARMA INC. | $10.2M | 2.78% | 1.5M | Hold |
| 11 | TARA | PROTARA THERAPEUTICS INC | $6.7M | 1.83% | 1.8M | Hold |
| 12 | AURA | AURA BIOSCIENCES INC | $6.6M | 1.80% | 929,077 | Added |
| 13 | LONA | LEONABIO, INC. | $5.8M | 1.59% | 634,539 | Hold |
| 14 | VSTM | VERASTEM INC | $5.6M | 1.53% | 1.5M | Hold |
| 15 | WHWK | WHITEHAWK THERAPEUTICS INC | $5.2M | 1.42% | 1.1M | Hold |
| 16 | QTTB | Q32 BIO INC. | $2.8M | 0.75% | 216,171 | Trimmed |
| 17 | ENGN | EUGENE THERAPEUTICS | $2.2M | 0.60% | 1.3M | New |
| 18 | JSPR | JASPER THERAPEUTICS | $604,027 | 0.16% | 1.4M | Added |
| 19 | BCAB | BIOATLA INC | $447,645 | 0.12% | 108,126 | Trimmed |
| 20 | CRDF | CARDIF ONCOLOGY INC | $0 | 0.00% | 0 | Exited |
| 21 | TERN | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
| 22 | XFOR | X4 PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
| 23 | VYNE | VYNE THERAPEUTICS INC | $926 | 0.00% | 1,425 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30